FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope?

Affiliations

• ¹ Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France. Electronic address: clara.helal@gustaveroussy.fr.
• ² Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France.
• ³ Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France; Department of Therapeutic Innovation and Early Trials, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France.
• ⁴ Medical Oncology Department, Institut Gustave Roussy, Université Paris Saclay, Paris, France; Department of Therapeutic Innovation and Early Trials, Institut Gustave Roussy, Université Paris Saclay, Villejuif, France. Electronic address: cristina.smolenschi@gustaveroussy.fr.